Quadriga Biosciences, Inc is a cutting-edge biotechnology company based in Los Altos, CA. They are dedicated to the development of QBS72S, a groundbreaking chemotherapeutic agent that utilizes the L-type Amino Acid Transporter 1 (LAT1) to penetrate the blood brain barrier and target rapidly growing cancer cells. By mimicking the structure of an aromatic amino acid, QBS72S acts as a Trojan Horse, gaining access to cancer cells and forming DNA interstrand cross-links that ultimately result in cell death.
Comprised of a team of oncology drug development leaders, Quadriga is committed to advancing novel oncology therapeutics. They stay at the forefront of their field by staying up-to-date with the latest announcements, publications, and more, ensuring they remain at the cutting edge of cancer treatment research and development.
Generated from the website